UNSPSC 51162337: Atropine/brompheniramine/phenyltoloxamine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162337 Atropine/brompheniramine/phenyltoloxamine/pseudoephedrine, a Commodity code, covers pharmaceutical products and related supplies that state and local governments procure for correctional healthcare, community health initiatives, and emergency response. Recent solicitations show state and local buying centered on parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems — moving beyond the specific combination drug name to encompass a broader family of injectable pharmaceuticals and opioid-response supplies. The Washington State Department of Corrections and Seminole County, Florida have posted opportunities under this code, representing correctional facilities and county public health agencies as primary issuing bodies. Bidders compete on delivery speed, ability to prepare custom formulations within tight timeframes, and compliance with state licensing and federal insurance requirements.

The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, seeking parenteral products and services for eight correctional facilities across three regions (West, Central, and East) with a response deadline of October 7, 2026; DOC anticipates awarding up to three contractors per region and requires custom parenteral nutrition preparations delivered within 24 hours, with all other parenteral products within eight hours. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the county community health building. Recent activity concentrates in Washington and Florida, with correctional healthcare and opioid-response programs as primary drivers. Both solicitations require firm fixed pricing, comprehensive insurance including cyber liability in the DOC case, and compliance with state procurement regulations including set-aside participation goals where applicable. The Washington opportunity carries aspirational small and diverse business targets (25% small business, 10% minority-owned, 6% women-owned, 5% veteran-owned), while the Seminole County procurement requires drug-free workplace certification and E-Verify compliance.